"3 ways the GLP-1 market has changed shape this year." August 2025
Some providers may support low-dose, infrequent use in select patients with documented cannabinoid medical necessity, but this requires informed consent, liver function assessment, and close monitoring
As a full ghrelin mimetic, it activates peripheral and central ghrelin receptor populations at once, producing appetite stimulation, elevated fasting glucose, and fluid accumulation in distal extremities as pharmacologically expected consequences rather than rare adverse effects
Dont forget: we also need to prescribe pen needles, as these are not supplied
For the last stubborn 20 pounds (lower back fat biggest repository) looking to stack CJC 1295 & Ipamorelin or AOD9604 with the tirzepatide